Smartphone App-Based Mindfulness Intervention for French and English Speaker Cancer Survivors
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorCanadian Cancer Trials Group
About this trial
There is a need to develop, evaluate, and disseminate self-directed, easily accessible, safe, affordable, and effective psychosocial interventions to people living with cancer (PLWC) post-treatment. Smartphone app-based health interventions are an innovative way to deliver psychosocial cancer-care. The Mindfulness-Based Cancer Survivorship (MBCS) Journey app is a mobile app format of the Mindfulness-based Cancer Recovery program. In the SEAMLESS Study, the investigators aim to evaluate the MBCS Journey app (a 4 week mind-body intervention) in cancer survivors post-treatment. This is a randomized wait-list controlled trial. Participants will either be assigned into the immediate group (will receive intervention immediately after enrollment) or the waitlist group (wait for 3 months before receiving the intervention).
Eligibility criteria
Qualifiers
Adult ≥ 18 years
Diagnosed with any type of cancer (stages I-IV)
Completed primary treatment (i.e. surgery, chemotherapy, radiation therapy) at least 2 weeks (14days) prior. Note: ongoing maintenance therapy, hormone-blocking therapies, intermittent bone-modifying agents, herceptin and targeted therapy with trastuzumab are not exclusionary.
Have access to a smartphone with data or wifi connection.
Disqualifiers
Major communication difficulties at the time of recruitment, as assessed by the research team (e.g. severe hearing impairment or cognitive impairment (score of ≤ 6; as assessed by the centre CRA using the three questions from the Brief Screen for Cognitive Impairment (BSCI)) listed in the screening CRF, which could interfere with completing the intervention and/or the questionnaires (i.e. inability to read or write)
Suffering from untreated Major Depressive Disorder or other psychiatric disorders that would interfere with participation. (Note: Participants will be referred for treatment and invited to call back once in remission).
Previous experience practicing in-person or app-based mindfulness once a week or more within the last year.
Trial design
Treatments tested in this trial
- Mindfulness
Treatment groups
345 Participants
are divided into 2 treatment groupsLocations
7Arthur J.E. Child Comprehensive Cancer CentreT2N 5G2, CalgaryAlberta, Canada
BCCA - KelownaV1Y 5L3, KelownaBritish Columbia, Canada
BCCA - Prince GeorgeV2M 7E9, Prince GeorgeBritish Columbia, Canada
BCCA - VictoriaV8R 6V5, VictoriaBritish Columbia, Canada
Sponsors and collaborators
Canadian Cancer Trials Group
Lead sponsor
Canadian Institutes of Health Research (CIHR)
Collaborator
Source ClinicalTrials.gov